Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
GD2特异性CAR-T细胞治疗GD2阳性转移性黑色素瘤和其他实体瘤患者的1期临床试验的安全性和生物学结果
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008659
Gargett, Tessa; Truong, Nga T H; Gardam, Bryan; Yu, Wenbo; Ebert, Lisa M; Johnson, Amy; Yeo, Erica C F; Wittwer, Nicole L; Tapia Rico, Gonzalo; Logan, Jesikah; Sivaloganathan, Purany; Collis, Maria; Ruszkiewicz, Andrew; Brown, Michael P